# Therapeutic Effect and Safety Study of Decitabine in Elderly Acute Myeloid Leukemia Patients

> **NCT01633099** · PHASE3 · UNKNOWN · sponsor: **Jianxiang Wang** · enrollment: 46 (estimated)

## Conditions studied

- Untreated Adult Acute Myeloid Leukemia
- Effect of Drugs
- Drug Safety

## Interventions

- **DRUG:** Decitabine

## Key facts

- **NCT ID:** NCT01633099
- **Lead sponsor:** Jianxiang Wang
- **Sponsor class:** UNKNOWN
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-05
- **Primary completion:** 2014-07
- **Final completion:** 2016-07
- **Target enrollment:** 46 (ESTIMATED)
- **Last updated:** 2012-07-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01633099

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01633099, "Therapeutic Effect and Safety Study of Decitabine in Elderly Acute Myeloid Leukemia Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01633099. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*